Elisabetta Maffei, Immacolata Cozzolino, Pio Zeppa, Alessandro Caputo
{"title":"From the Franzen-KIFA Handle up to Digital Cytopathology: The Long Story of Lymph Node Fine-Needle Aspiration Cytology.","authors":"Elisabetta Maffei, Immacolata Cozzolino, Pio Zeppa, Alessandro Caputo","doi":"10.1159/000553609","DOIUrl":"10.1159/000553609","url":null,"abstract":"<p><strong>Background: </strong>Lymph node fine-needle aspiration cytology (FNAC) has a history spanning more than a century, reflecting advances in cytology, pathology, and related technical disciplines. Lymph nodes were among the earliest targets of FNAC, which is now used to diagnose a broad spectrum of pathological processes, ranging from reactive conditions to lymphomas and metastases.</p><p><strong>Summary: </strong>To address these diverse settings, nearly all ancillary techniques used in pathology practice have been applied to lymph node FNAC, with their use tailored to the pathological process, the quality and quantity of diagnostic material, and the clinical context. Over time, this evolution has also led to the development of different technical procedures, diagnostic algorithms, and classification systems. Despite its achievements and potential, lymph node FNAC is still not universally accepted and remains subject to skepticism among some clinicians and criticism from some pathologists. In many aspects, lymph node FNAC represents a paradigm of clinical cytology, and its history reflects both the period in which it evolved and the environments in which it has been practiced. This review retraces the development of lymph node FNAC from the dawn of cytopathology to the present, highlighting its major advances, current role, and future perspectives.</p><p><strong>Key messages: </strong>Lymph node FNAC has evolved into a versatile diagnostic tool for reactive, neoplastic, and metastatic lymph node lesions. The integration of ancillary techniques, technical innovations, and standardized classification systems has substantially expanded its diagnostic capabilities. Understanding the historical evolution of lymph node FNAC provides insight into its current role, ongoing limitations, and future perspectives in modern cytopathology.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-22"},"PeriodicalIF":1.5,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148468269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ashish Chandra, Ralf Heine, Leonie Wheeldon, Sinchita Roy-Chowdhuri, Merce Jorda, Claire W Michael, Guoping Cai
{"title":"Serous Fluid Cytopathology: Landmark Developments in Techniques, Terminology, and Clinical Application.","authors":"Ashish Chandra, Ralf Heine, Leonie Wheeldon, Sinchita Roy-Chowdhuri, Merce Jorda, Claire W Michael, Guoping Cai","doi":"10.1159/000553613","DOIUrl":"10.1159/000553613","url":null,"abstract":"<p><strong>Background: </strong>This invited review for the special issue is a celebration of the continued growth of knowledge in the field of serous fluid cytopathology.</p><p><strong>Summary: </strong>The review begins by addressing the value of cytological examination of the fluid samples in conjunction with clinical, radiological, and biochemical data interpreted by the treating physician. It then covers the advances in cytopreparatory techniques with special reference to existing and emerging ancillary techniques available to obtain maximal diagnostic, prognostic, and therapeutic information for the practice of precision medicine. The concept of mesothelioma as a cytological diagnosis has been made possible in recent years through clinical research and advocacy by experts and this has added value to serous fluid samples especially when this is the only sampling method available for a patient. Advances in the recommended repertoire of immunostains and a standardized approach through the use of diagnostic categories has been made possible by The International System for Reporting Serous Fluid Cytopathology. The reporting system has found application to other types of fluid samples, most recently, cerebrospinal fluid cytology, which will be included in the forthcoming edition of the terminology system and is introduced in this special issue.</p><p><strong>Key messages: </strong>The review charts a journey commemorating important landmarks in our current understanding of serous fluids in diagnostic cytopathology.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-24"},"PeriodicalIF":1.5,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148468251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Md Ali Osama, Zarine Kamaluddin, Lukas Bubendorf, Deepali Jain
{"title":"Predictive Immunohistochemical Biomarkers for Antibody-Drug Conjugate Therapy in Pulmonary Cytology.","authors":"Md Ali Osama, Zarine Kamaluddin, Lukas Bubendorf, Deepali Jain","doi":"10.1159/000553423","DOIUrl":"10.1159/000553423","url":null,"abstract":"<p><strong>Background: </strong>The management of lung cancer has undergone a major transformation with the advent of precision oncology, where treatment decisions increasingly rely on tumor-specific biomarkers rather than morphology alone. In advanced-stage disease, pulmonary cytology specimens are often the only diagnostic material available. Cytological preparations are increasingly important in the workup of NSCLC. Cell blocks are among the available preparation methods that can be used for morphological evaluation and ancillary testing, including immunohistochemistry (IHC) and molecular studies. With advances in transcriptomic and proteomic profiling, several novel biomarkers have emerged beyond conventional lineage-specific markers, expanding the role of IHC in prognostication, prediction of therapeutic response and therapeutic selection. This has become particularly important in the era of antibody-drug conjugates (ADCs), which selectively target tumor-associated antigens while minimizing damage to normal tissue.</p><p><strong>Summary: </strong>Cytology preparations, in all their forms, have become increasingly important in the diagnostic and predictive evaluation of non-small cell lung carcinoma (NSCLC). IHC remains one of the most practical and widely accessible methods for biomarker assessment, particularly in resource limited settings. Several ADC-related biomarkers, including HER2, MET, TROP2, and HER3 have recently gained therapeutic relevance, with multiple targeted agents either approved or under active clinical investigation. In addition, emerging biomarkers such as MTAP deficiency further broaden the predictive biomarker landscape and can be reliably assessed using IHC. This review summarizes the current understanding and evolving data regarding immunohistochemical biomarkers in pulmonary cytology, with special emphasis on ADC-related markers and their application in cell block preparations. The biological rationale, diagnostic utility, therapeutic implications, interpretation criteria, and limitations of these biomarkers are discussed.</p><p><strong>Key messages: </strong>Various cytological preparations from pulmonary cytology specimens can be used for diagnostic and predictive biomarker testing in lung carcinoma. IHC-based evaluation of emerging biomarkers is increasingly important for guiding personalized therapy, particularly in the context of ADCs and targeted treatment strategies. A clear understanding of the interpretation and limitations of these biomarkers is essential for pathologists involved in thoracic cytopathology and precision oncology.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-11"},"PeriodicalIF":1.5,"publicationDate":"2026-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148395370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ivana Kholová, Christine N Booth, Henrik Edvardsson, Ritu Nayar, Giovanni Negri, Liron Pantanowitz
{"title":"The Development Path of Gynecological Cytology after Papanicolaou: From Bethesda to Artificial Intelligence and Personalized Medicine.","authors":"Ivana Kholová, Christine N Booth, Henrik Edvardsson, Ritu Nayar, Giovanni Negri, Liron Pantanowitz","doi":"10.1159/000552509","DOIUrl":"10.1159/000552509","url":null,"abstract":"<p><strong>Background: </strong>Cervical cancer is the fourth most common cancer whose incidence was significantly reduced with the help of Pap smear and organized cervical cancer screening. Implementation of HPV vaccination and addition of HPV primary screening, automation, and most recently digitalization and application of artificial intelligence have taken cervical cancer prevention into a new era.</p><p><strong>Summary: </strong>This review paper covers gynecological cytology from terminology and shows The Bethesda System as a model for further terminology systems. Liquid-based cytology enabled the application of ancillary techniques elegantly from one vial as well as digitalization and the implementation of artificial intelligence. HPV primary screening further shaped the field and led to the decline of cytology volumes. Nevertheless, genotyping and dual staining allow the implementation of personalized medicine in screening scenarios.</p><p><strong>Key messages: </strong>The field of gynecological cytology has slowly but surely evolved from the conventional Pap smear to liquid-based cytology, automation, and now digitalization, artificial intelligence, and inclusion of HPV testing with genotyping enabling personalized prevention in cervical cancer screening and diagnostics.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-13"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148366565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cytological Features of CIC-Rearranged Sarcoma: A Report of 5 New Cases and Review of the Literature.","authors":"Pawel Gajdzis, Jerzy Klijanienko","doi":"10.1159/000553217","DOIUrl":"10.1159/000553217","url":null,"abstract":"<p><strong>Introduction: </strong>CIC-rearranged sarcoma is a rare, Ewing-like round cell sarcoma and is poorly described in the cytology literature, with only seven cases reported to date.</p><p><strong>Methods: </strong>This report presents five new cases investigated and treated at the Institut Curie (four tumours showed CIC-DUX4 and one showed CIC-NUTM1 fusions) and reviews corresponding cytological literature.</p><p><strong>Results: </strong>Smears were cellular in all cases. They comprised of isolated and clustered round, oval, and short spindle cells, with rosettes in three cases. Cytoplasm varied in volume and occasionally showed microvacuolation. Marked pleomorphism and rhabdoid features were detected in one CIC-NUTM1 sarcoma and in one CIC-DUX4 sarcoma. CD99 was positive in three cases and negative in two. Original cytologic diagnoses included two round cell sarcomas (one with myxoid features), pleomorphic sarcoma with rhabdoid features, Ewing sarcoma, and rhabdomyosarcoma.</p><p><strong>Conclusion: </strong>Fine-needle aspiration appears to be at least as effective as core-needle biopsy for these malignancies. Cytomorphological features, together with the immunohistochemical profile and detection of CIC rearrangements, can help accurately diagnose this rare malignancy.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-8"},"PeriodicalIF":1.5,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148359054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pericardial Fluid Metastatic Tumor Distribution and Fluid Volume Analysis: A 10-Year Institutional Experience.","authors":"Mason Marshall, Timothy Ramseyer, Jacqueline Cuda, Andrea Jurado, Joshua Pantanowitz, Liron Pantanowitz, Samer Khader","doi":"10.1159/000553127","DOIUrl":"10.1159/000553127","url":null,"abstract":"<p><strong>Introduction: </strong>Cytologic examination of pericardial effusions is critical for detecting malignant involvement, which carries a dismal prognosis. However, contemporary large-scale studies characterizing the distribution of metastatic tumors and the impact of submitted fluid volume on diagnostic yield remain limited. This study evaluates the distribution of metastatic tumors in malignant pericardial effusions and examines the relationship between specimen volume and likelihood of malignant cytologic diagnosis in a large institutional cohort.</p><p><strong>Methods: </strong>A 10-year retrospective review was performed of all pericardial fluid cytology specimens accessioned at a large tertiary academic medical center. Clinical, radiologic, and cytologic findings were recorded. Cases categorized as suspicious for malignant cells (SFM) or malignant (MAL) were included in the metastatic tumor distribution analyses after reviewing tumor cytomorphology and immunohistochemical profiles in conjunction with clinical and radiologic data. Specimen volumes were stratified by diagnostic category, and threshold-based analyses at 50 mL and 100 mL were compared across diagnostic categories using statistical methods.</p><p><strong>Results: </strong>A total of 1,591 cases were identified from patients with a median age 65 years and a male-to-female ratio of 0.98. Most cases were negative for malignant cells (NFM) (78.6%), while 14.4% classified as malignant (MAL). Among malignant cases (SFM + MAL), carcinomas accounted for 83.5%, followed by hematolymphoid malignancies (14.0%); mesotheliomas, sarcomas, and melanomas were rare. Lung carcinoma was the most common primary tumor (48.0%), followed by breast carcinoma (16.0%) and B-cell lymphoma (7.8%). Submitted specimen volume increased progressively across diagnostic categories (p = 0.0010), with malignant cases demonstrating higher median volumes than negative cases. Specimens ≥50 mL showed a significantly higher malignancy rate compared with those <50 mL (18.4% vs. 10.6%, p < 0.001), corresponding to nearly twofold higher odds of malignancy (OR 1.91, 95% CI: 1.43-2.55). A smaller but statistically significant association was observed at the 100 mL threshold (OR 1.35, 95% CI: 1.06-1.82), with no additional benefit at higher thresholds.</p><p><strong>Conclusions: </strong>In this 10-year institutional experience, malignant pericardial effusions were overwhelmingly metastatic in origin, most commonly arising from lung and breast carcinomas and hematolymphoid malignancies. Awareness of the metastatic distribution to the pericardium enhances diagnostic confidence and guides immunohistochemical workup on specimens with limited cellularity. Submitted fluid volume was significantly associated with a malignant cytologic diagnosis, with volumes ≥50 mL conferring nearly twofold increased odds of malignancy and diminishing incremental benefit beyond 100 mL. These findings support submission of at least 50 mL of","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-10"},"PeriodicalIF":1.5,"publicationDate":"2026-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148282856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Cytopathology of Infectious Disease: A Review.","authors":"Pamela Michelow, Charlotte Sriruttan-Nel","doi":"10.1159/000553052","DOIUrl":"10.1159/000553052","url":null,"abstract":"<p><strong>Background: </strong>Infectious diseases continue to represent a major global burden, remaining among the leading causes of morbidity and mortality. Cytopathology is a valuable diagnostic tool across diverse healthcare settings, including both high-income and low- and middle-income countries for diagnosis of infection. Its cost-effectiveness and ability to provide rapid results make it particularly well suited for timely clinical decision-making, which can be critical and, in some cases, lifesaving in a patient with an infectious disease. While cytopathology often yields sufficient information for diagnosis, confirmatory ancillary techniques, such as microbiological studies, immunocytochemistry, and molecular assays, may be necessary in selected cases to establish a definitive diagnosis.</p><p><strong>Summary: </strong>The practicing cytopathologist and cytologist must be familiar with the cytomorphologic diagnosis of infection. This review article highlights the cytomorphologic features of infectious diseases that can be diagnosed cytologically, the utility of ancillary tests, and discusses both the advantages and limitations of cytopathology in this context.</p><p><strong>Key message: </strong>Careful and systematic attention to cytomorphologic features, including both the infectious agents and the characterisation of the host tissue response, together with clinicoradiologic correlation and the judicious application of ancillary diagnostic tests, is essential for achieving an accurate diagnosis of infection. Such an integrated approach minimises the risk of false-negative and false-positive interpretations, ensures specimens are appropriately classified within the correct cytologic reporting category, and facilitates informed decisions regarding the selection of ancillary investigations.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-19"},"PeriodicalIF":1.5,"publicationDate":"2026-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148256907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Investigation of a Storage Method for Peritoneal and Pleural Effusion Cytology Specimens for Long-Term Preservation of Antigenicity in Immunocytochemical Staining.","authors":"Dai Yamaguchi, Ken-Ichi Mukaisho, Naoko Taniura, Akiko Harada, Muneo Iwai, Machiko Tanimura, Yuji Hayashi, Suzuko Moritani, Ryoji Kushima","doi":"10.1159/000552980","DOIUrl":"10.1159/000552980","url":null,"abstract":"<p><strong>Introduction: </strong>Additional immunocytochemical staining is frequently required in routine cytodiagnosis to refine presumptive diagnoses. However, optimal conditions for preserving antigenicity in cytological specimens over time remain unclear. This study evaluated the effects of preparation method, storage temperature, and storage duration on antigen preservation in clinical cytology specimens and cultured malignant tumor cells.</p><p><strong>Methods: </strong>Residual sediments from 12 pleural or ascitic fluid cytology specimens were fixed in BD CytoRich Red for 1 h and processed using the SurePath liquid-based cytology method. Immunocytochemical staining performed immediately after preparation served as the baseline control. Specimens were stored as glass smears or in preservative fluid at 4°C or -20°C for 1 week, 1 month, or 3 months. Ki-67 and calretinin were used as primary antibodies. To reflect routine cytology practice, Papanicolaou-stained (Pap-stained) preparations were also included. Cultured malignant tumor cell lines (TCC-Meso-1, MCF-7, and KATO-III) were prepared as Pap-stained, coverslipped slides, and stored at room temperature.</p><p><strong>Results: </strong>In clinical glass smears, neither Ki-67 nor calretinin showed a significant decline compared with baseline across storage conditions. In preservative fluid, Ki-67 positivity differed from glass smears and was associated with storage temperature; 4°C storage resulted in significant reductions from 1 week onward. At -20°C, reductions were limited, although selected short-term comparisons with baseline reached statistical significance. In clinical Pap-stained preparations, Ki-67 showed a significant time-dependent decrease evident at 3 months, with a similar pattern observed for calretinin. In FDR-adjusted comparisons with the non-stored baseline, Pap-stained samples exhibited the greatest reductions in rate ratios, whereas most cooled non-Pap preparations retained relatively preserved immunopositivity. In cultured Pap-stained cell preparations, Ki-67 reductions were modest and tumor type-related, with no decrease observed in TCC-Meso-1 cells.</p><p><strong>Conclusion: </strong>Fixation followed by glass smear preparation and low-temperature storage (4°C or -20°C) allows relatively stable preservation of Ki-67 and calretinin immunoreactivity. Storage at -20°C may be preferable when longer preservation periods are required. In contrast, delayed immunocytochemical staining of Pap-stained specimens may result in tumor type-related variability in Ki-67 immunoreactivity and therefore should be interpreted with caution.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-12"},"PeriodicalIF":1.5,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148222462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dinesh Kumar Ambati, Pooja K Suresh, Rakshatha Nayak, Hema Kini, Jyoti R Kini, Sridevi H Basavaiah, Ranjita Devi Chongtham, Akhil Kocherlakota
{"title":"Diagnostic Utility of Endoscopic Crush Cytology in Gastrointestinal Malignancies.","authors":"Dinesh Kumar Ambati, Pooja K Suresh, Rakshatha Nayak, Hema Kini, Jyoti R Kini, Sridevi H Basavaiah, Ranjita Devi Chongtham, Akhil Kocherlakota","doi":"10.1159/000552792","DOIUrl":"10.1159/000552792","url":null,"abstract":"<p><strong>Introduction: </strong>Gastrointestinal (GI) cancers represent one of the most pressing global public health challenges, accounting to nearly one-third of all cancer-related mortality worldwide. Cytological evaluation allows rapid interpretation and triaging of material. Crush cytology is an added asset to histology to maximize diagnostic accuracy and accelerate decision-making for the management of these lesions. This study aimed to assess the diagnostic utility of endoscopic crush cytology in GI tract lesions.</p><p><strong>Methods: </strong>A cross-sectional observational study was conducted on GI crush cytology samples received at department of pathology from January 2019 to December 2024. These cases were cytologically categorized across various GI sites as follows, negative for malignancy, atypical favors reactive, atypical suspicious for malignancy and positive for malignancy. The corresponding biopsy slides were reviewed and documented. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were calculated.</p><p><strong>Results: </strong>During the study period, we reviewed 303 cases of GI crush cytology. The mean age at presentation was 60 years (age range: 17-90 years) with a male-to-female ratio of 2:1. These cases were categorized into lower GI with 151 (49.8%) cases and upper GI with 152 (50.2%) cases. The most common site of involvement was colorectal with 146 (48.2%) cases followed by gastric region with 58 (19.1%) cases and esophagus with 31 (10.2%) cases. Negative for malignancy accounts for 7 (2.3%) cases, atypical favors reactive accounts for 120 (39.6%) cases, atypical suspicious for malignancy accounts for 4 (1.3%) cases, and positive for malignancy accounts for 172 (56.8%) cases across the GI region. Histopathology correlation was available in 179 (59.1%) cases. The overall GI crush cytology sensitivity was 96.1%, specificity was 96.2%, PPV was 98.4%, NPV was 90.9% and the diagnostic accuracy was 96.1%. The Youden's index was 0.9222, and the p value was <0.001 (χ2).</p><p><strong>Conclusion: </strong>Crush cytology is a highly sensitive, specific, rapid, and cost-effective technique for diagnosing GI malignancies in endoscopically suspected malignant lesions. It is a valuable complement to histology, enhancing diagnostic accuracy and accelerating decision-making to manage these lesions. The present study highlights the significant diagnostic utility of crush cytology by demonstrating high sensitivity, specificity, and diagnostic accuracy, particularly in detecting adenocarcinomas and squamous cell carcinomas.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-15"},"PeriodicalIF":1.5,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13395394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148203704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Illuminating the Past to Understand the Present: The Life and Legacy of Ruth Moore Graham.","authors":"Joy M Hoang, Güliz A Barkan","doi":"10.1159/000552777","DOIUrl":"10.1159/000552777","url":null,"abstract":"","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-4"},"PeriodicalIF":1.5,"publicationDate":"2026-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148194321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}